Last updated on November 2019

Observational Study to Evaluate Under Real-world Practice Conditions the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC)

Brief description of study

Observational study to evaluate, under real-world practice conditions, the safety and effectiveness of regorafenib in patients diagnosed with unresectable hepatocellular carcinoma (uHCC)

Clinical Study Identifier: NCT03289273

Find a site near you

Start Over

Lahey Hospital & Medical Center

Burlington, MA United States
  Connect »